Webseite regulanet.com

HealthHelp, a leading specialty benefit management provider, continues to target health care cost drivers by adding diagnostic cardiac catheterization to its well-established and effective suite of services.

Venn Life Sciences would like to announce the appointment of Dale Trask as Vice President Global Business Development, marking an important phase in the company's growth. Mr. Trask brings extensive experience in Clinical Research Organisation (CRO) business development and will be responsible for enhancing Venn's business partnerships, strategic relationships and growth into new markets.

Medifocus Inc. (OTC:MDFZF.PK and TSXV:MFS) is pleased to announce that it has received from the Food and Drug Administration (FDA) an Investigational Device Exemption (IDE) approval to initiate a pivotal Phase III clinical trial upon obtaining institutional review board (IRB) approval from the clinical sites, using the Company's Microfocus APA 1000 System for the treatment of breast cancer. Medifocus had already announced on June 9, 2009 that Health Canada had granted full Investigational Testing Authorization (ITA) approval to allow the initiation of the same pivotal Phase III study in Canada.

It's long been known that obesity is linked to increased risk of developing colon cancer, but now researchers at the Mayo Clinic campus in Minnesota have found that obesity is associated with worse outcomes in patients who have already been diagnosed and treated for the cancer.

Premier Purchasing Partners, LP, today announced a new agreement for OR equipment drapes has been awarded to Microtek Medical Inc. of Alpharetta, Ga.

Rosetta Genomics, Ltd. (NASDAQ: ROSG), a leading developer of microRNA-based molecular diagnostics, announced that Kenneth A. Berlin, president and chief executive officer, will be presenting a corporate update at the 22nd Annual Roth OC Growth Stock Conference on Tuesday, March 16, 2010 at 3:30 p.m. (Pacific Time) at the Ritz Carlton Laguna Niguel in Dana Point, California.

Inhibitex, Inc. (NASDAQ: INHX) announced today that it will host a conference call on Tuesday, March 23, 2010 at 9:00 a.m. EST to review the Company's fourth quarter and year-end December 31, 2009 financial results and provide an update on recent corporate developments. The Company will issue a press release regarding its financial results on the same day, prior to the conference call.

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the 22^nd Annual ROTH OC Growth Stock Conference on Tuesday, March 16, 2010, at 3:00 p.m. PT (6:00 p.m. ET) at the Ritz-Carlton, Laguna Niguel in California.

Medical Compression Systems, Ltd. (TASE:MDCL), a company specializing in innovative non-invasive blood circulation solutions, today announced the appointment of Ambaw Bellete to the position of president of its U.S. subsidiary, Medical Compression Systems, Inc. Mr. Bellete brings with him more than 20 years of management experience from executive positions in business development, marketing and sales in the medical device and pharmaceutical industries with an emphasis on thrombosis, cardiology, immunology and cardiology. Most recently, Ambaw served as vice president at Sanofi Aventis for the Orthopedic and Urology Franchise business including leading the commercial efforts in orthopedics for Lovenox^® (enoxaparin sodium injection).

Pernix Therapeutics Holdings, Inc. (NYSE Amex:PTX) ("the Company") today announced that the Company will present at the Cowen and Company 30th Annual Health Care Conference at the Marriott Copley Place in Boston.

First Lady Michelle Obama's "Let's Move" Campaign tells us that about 32 percent of children and teens (or 25 million) are obese or overweight. It revealed those extra pounds put them at greater risk of developing debilitating and costly diseases including diabetes, high blood pressure and high cholesterol and may also cause them to lead a two to five year shorter life than their parents.

BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced the closing of the sale, directly to funds affiliated with two institutional investors, of an aggregate of approximately 10.4 million shares of BioSante's common stock and warrants to purchase up to approximately 5.2 million shares of its common stock, resulting in gross cash proceeds to BioSante of $18 million. The investors are Great Point Partners, LLC and Deerfield Management Company. BioSante received net proceeds of approximately $17.5 million after deducting placement agent fees and other estimated offering expenses. Each unit, consisting of one share of common stock and a warrant to purchase 0.5 of a share of common stock, was sold for a purchase price of $1.73, which is equal to the closing price of BioSante's common stock on the day before the securities purchase agreements were signed, as reported by the NASDAQ Stock Market.

Despite the uncertainty of health care reform, most U.S. employers say they are continuing to make investments today that will improve the long-term health and productivity of their workforce, according to a new survey by Hewitt Associates, a global human resources consulting and outsourcing company. But while well-intentioned, Hewitt's survey shows most companies are just beginning to consider and implement the types of strategies, tactics and goals that will create positive and sustainable improvements in employee health and constrain escalating health care costs.

QuadraMed^® Corporation (NASDAQ:QDHC), a leading provider of healthcare information technologies and services that help turn quality care into positive financial outcomes, announced today that on March 8, 2010, the Court of Chancery of the State of Delaware issued an opinion denying LC Capital Master Fund, Ltd.'s motion for a preliminary injunction of QuadraMed's proposed acquisition by Francisco Partners.

Research and Markets (http://www.researchandmarkets.com/research/ef97e2/consumer_health_n) has announced the addition of the "Consumer Health: New Product Developments in 2009/2010" report to their offering.

Corporate Translations, Inc., a leading translation service provider specializing in the life science industry, has recently switched from Trados to the Across Language Server for its translation management software. The company indicates that the Across technology better meets its core values of speed, accuracy, flexibility and innovation; Corporate Translations will move all of its suitable translation projects to the Across Language Server over the course of 2010.

Research and Markets(http://www.researchandmarkets.com/research/2c52fb/neuro_and_musculos) has announced the addition of the "Neuro and Musculoskeletal Imaging" training to their offering.

Medtronic, Inc., (NYSE: MDT), today announced William A. Hawkins, chairman and CEO, recently received the Biomedical Engineering Society's Distinguished Achievement Award. As part of the award, the plenary lecture he delivered to the organization was published in the March 2010 edition of the Annals of Biomedical Engineering. The Distinguished Achievement Award is given to a company, charitable foundation, or nonacademic institution that has made great contributions to the field of biomedical engineering/bioengineering.

biospace med (www.biospacemed.com), an emerging medical technology company based in Paris, and Oldelft Benelux, a renowned specialist in medical diagnostic imaging, announced today the signature of an exclusive distribution agreement of EOS, the world's first ultra-low-dose 2D|3D imager. The agreement will cover the distribution of EOS for the Benelux area (Belgium, The Netherlands & Luxembourg).

Fitch Ratings has affirmed Amgen Inc. (Amgen) ratings as follows:

Research and Markets(http://www.researchandmarkets.com/research/7bc958/us_markets_for_rep) has announced the addition of the "US Markets for Reprocessed Devices 2009" report to their offering.

Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that its Board of Directors received a letter from Mr. Eli Hurvitz indicating that he wishes to be released from his duties at Teva in order to focus on his full recovery. Accordingly, Professor Moshe Many has stepped down from his role as Interim Chairman and following deliberations held by the Board of Directors and in accordance with the recommendation of the Nomination Committee, the Board has unanimously appointed its Vice Chairman, Dr. Phillip Frost, to serve as Chairman of the Board of Directors.

Provectus Pharmaceuticals, Inc. (OTCBB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, announced today that it has signed agreements with various institutional and accredited investors for the private placement of an aggregate of approximately 7.1 million shares of its convertible preferred stock and warrants to purchase approximately 3.55 million shares of its common stock at an exercise price of $1.00 per share pursuant to a Securities Purchase Agreement. The Company will receive gross proceeds of $5.3 million. The shares to be issued to the investors and the shares underlying the warrants have not been and will not be registered under the Securities Act of 1933, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

Digestive CARE™, a medical group of more than 50 gastroenterologists in Broward and Palm Beach County, today announced that it is receiving hundreds of online votes in its "Bottom Line Song Title Contest" to bring awareness to National Colorectal Cancer Awareness Month (March 2010).

Exelixis, Inc. (Nasdaq:EXEL) today reported financial results for the fourth quarter and year ended December 31, 2009.

Research and Markets (http://www.researchandmarkets.com/research/df4dc3/growth_opportuniti) has announced the addition of the "Growth Opportunities for Left Ventricular Assist Devices (LVAD) in Heart Failure Market" report to their offering.

Today, FreeSlate, Inc. announced its launch as an independent company focused on delivering integrated workflow solutions for R&D organizations seeking to maximize productivity and enhance innovation. FreeSlate, which previously operated as the High Productivity Research (HPR) business unit of Symyx Technologies, provides researchers with increased experimental capacity and faster decision-making via its microscale, high-throughput technology, lab execution and analysis software, and experienced engineers and application scientists.

CEOcast.com., a financial portal providing coverage of emerging growth companies, announced today that it conducted an online interview with Bruce A. Shear, president and CEO of PHC, Inc., d/b/a Pioneer Behavioral Health (NYSE Amex: PHC), , a leading provider of inpatient and outpatient behavioral health services. In the interview, Mr. Shear discussed the company's recent decision to open a ten-bed adolescent unit at its Seven Hills Behavioral Institute (SHBI) in Henderson, Nevada. The Hospital provides psychiatric, alcohol and drug addiction treatment for adolescents and adults. Mr. Shear noted that he expects the new Unit to generate $2 million in annual revenue and strong operating margins, which are expected to generate an incremental 3 cents per share in annual earnings. For the first six months of its fiscal year ended December 31, 2009, PHC earned 3 cents per share.

Bond Laboratories, Inc. (OTCBB:BNLB), a manufacturer of innovative nutritional supplements and functional beverages, today announced the addition of another Anheuser-Busch® distributor to its Fusion Premium Beverages' products distribution network. Quality Brands of Omaha Inc., the largest beer distributor in the state of Nebraska, provides Fusion Premium Beverages with access to more than 1,100 on and off premise accounts throughout the Omaha territory they service.

Emerging Healthcare Solutions, Inc. (Pink Sheets: EHSI). The healthcare industry continued its strong trend towards growth by adding 12,000 jobs in February, according to US Bureau of Labor Statistics. Total seasonally adjusted employment for healthcare, which includes hospitals, ambulatory care centers, nursing facilities and residential care facilities, was 13.67 million – up from 13.65 million in January of 2010.

Aternity Inc., the industry's technology leader in end user experience management solutions for Global 1000 enterprises, announced today that Ministry Health Care, a values-driven health care delivery network of aligned hospitals, clinics and other providers, has selected the Aternity Frontline Performance Intelligence (FPI) Platform for its strategic end user experience management initiatives. With Aternity, Ministry Health Care is monitoring and analyzing the performance of its Electronic Health Record (EHR) systems including GE Centricity® EMR and CattailsMD™ EHR.

Campbell Soup Company (NYSE:CPB) today announced three winners of the company's "Lifestyle Change Award," a program designed to recognize employees who have made healthy lifestyle changes, positively influenced others to improve their health or achieved a health-related goal.

The Association of Hole in the Wall Camps and the Hole in the Wall Foundation are pleased to announce the appointment of John Reid as their new President and CEO. John assumes the role from Ray Empson who is retiring from the organization.

Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, today announced that its President and CEO, David Bupp, will present at the Roth Capital Partners 22^nd Annual OC Growth Stock Conference on Monday, March 15, 2010 at 4:00 PM PST. The conference is taking place at the Ritz-Carlton in Laguna Niguel, CA. Mr. Bupp will provide a corporate overview, including an update and discussion of the clinical and regulatory status of Neoprobe's two drug development products, Lymphoseek^® and RIGScan™ CR.

Xplore Technologies Corp. (OTCBB: XLRT), a maker of award-winning rugged mobile computers, today announced the launch of a new unit specifically designed for use in clean rooms. "The Clean Room iX104C4 Tablet PC represents a significant opportunity for Xplore and is an application of our technology that we believe will deliver significant value to clean room users," said Mark Holleran, President and Chief Operating Officer of Xplore Technologies. Xplore is a leader in fully rugged tablet PCs according to industry reports.

Research and Markets (http://www.researchandmarkets.com/research/920e0d/european_markets_f) has announced the addition of the "European Markets for Acute Care Clinical Information Systems 2009" report to their offering.

Sartorius (FWB:SRT), ein international führender Labor- und Prozess-ausstatter, hat seinen operativen Gewinn im Jahr 2009 trotz der schwierigen gesamt-wirtschaftlichen Rahmenbedingungen gesteigert und ein operatives Ergebnis von 60,9 Mio. Euro nach 56,8 Mio. Euro im Vorjahr erzielt. "Damit zählen wir zu den Unternehmen, die das Krisenjahr 2009 mit einer positiven operativen Ertragsentwicklung abschließen konnten", kommentierte Konzernchef Dr. Joachim Kreuzburg die Jahresergebnisse auf der Bilanzpressekonferenz in Göttingen.

Muscle Flex Inc. (www.MuscleFlex.com) (Pink Sheets:MFLI) announced today that it has reviewed the first edits of The Complete Package™ (www.TheCompletePackageTV.com) Reality TV Show pilot and opening episode as well as the two-minute sizzle reel and has exceeded its expectations in every measure. TLK Fusion (www.TLKFusion.com), BRAVADA / Muscle Flex's partner in The Complete Package which includes Wesley Morris Entertainment (www.WesleyMorris.com), have been engaged in substantive discussions with a number of high profile Hollywood entities and power brokers with regards to The Complete Package and have received a tremendous degree of interest. As well, a growing list of high profile national media and nationally syndicated talk shows and programs have requested and are awaiting copies of the two-minute Complete Package sizzle reel which shall be released to the media and the public. The release date of The Complete Package sizzle reel is expected the week of March 15^th.

Instem, a leading provider of early drug development software solutions, announced today that Mitsubishi Chemical Medience Corporation (MCM) has purchased the Provantis preclinical software solution.

Morinaga Milk Industry Co., Ltd. (TOKYO:2264), the second-largest dairy company in Japan, today announced it has received a no objection letter from FDA in response to its GRAS notification for the proprietary probiotic strain Bifidobacterium longum BB536. The official FDA affirmation that the ingredient is GRAS paves the way for the highly researched probiotic to be included in functional foods.

Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced the commencement of the "Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus" trial (SAVOR-TIMI 53), a multicenter, randomized, double-blind, placebo-controlled Phase 4 study, to evaluate treatment with ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 (DPP4) inhibitor, in adult type 2 diabetes patients with cardiovascular risk factors. The five-year study will follow approximately 12,000 patients with type 2 diabetes, who have either a history of previous cardiovascular events or multiple risk factors for vascular disease, and includes patients with renal impairment.

Medical Banking Rx, LLC, a full service pharmacy benefit management (PBM) firm, today announced that it has received the 2010 Healthcare Information and Management Systems Society (HIMSS) Medical Banking Project Disruptive Innovator Award. The Disruptive Innovator Award was in recognition of the development of Patient Driven Rx^SM, a truly unique prescription drug program that provides real-time solutions to the deficiencies inherent in the Consumer Driven Health (CDH) market. The award was presented during the 8^th National Medical Banking Institute segment of the HIMSS 2010 Annual Conference, in Atlanta, Georgia.

Premier supplements maker Coromega^® today unveiled Coromega Omega3 + Vitamin D, a delicious squeeze supplement that provides a daily dose of omega-3s with added vitamin D_3, and Coromega Omega3 Fruit Gummies, a high-DHA chewable gummy supplement for the kid in everyone.

Chronix Biomedical today announced publication of a study that supports the utility of its serum DNA blood tests for the early and accurate detection of breast cancer. The Chronix tests detect the circulating DNA that is released into the blood stream by damaged and dying cells. A growing body of publications from Chronix and other researchers shows that this circulating DNA can be identified and analyzed to provide a diagnostic window into ongoing changes in the genome associated with specific diseases—changes that can be used to identify disease processes at an early stage and to track responses to treatment. This new study shows that the Chronix approach was able to detect invasive breast cancer with high diagnostic sensitivity and specificity, even at the earliest stage when tumors are very small. The findings are published in the current online edition of Molecular Cancer Research.*

Helix BioMedix, Inc. (OTCBB: HXBM), a developer of bioactive peptides, announced additional funding in the amount of $2.9 million through convertible promissory notes. The company also announced the addition of Lawrence Blake Jones to its board of directors.

HST Global, Inc., (OTCBB: HSTC) today announced that Dr. James Forsythe, MD, HMD, is experiencing continuous success with his Forsythe Immune Therapy (FIT) Protocol. Dr. James Forsythe, MD, HMD, is a board certified oncologist and a member of HST Global Inc.'s Board of Directors and Scientific Advisory Board.

Neurologix, Inc. (OTCBB:NRGX), a biotechnology company engaged in the development of innovative therapies for the brain and central nervous system, announced today that Marc Panoff, the company's Chief Financial Officer, will present at the Roth Capital Partners 22^nd Annual OC Growth Stock Conference. The conference will be held March 15 - 17 at The Ritz Carlton Laguna Niguel in Dana Point, CA.

Award-winning photographer Donald Verger today announced that he is donating an extraordinary pink rose image valued at $1,000 to support the Pink Tie Ball^™, an annual event of the Maine Affiliate of Susan G. Komen for the Cure, to be held March 20^th at the Holiday Inn by the Bay. Verger is also the Founder and President Emeritus of the world-renowned Children's Discovery Museum and Science Discovery Museum in Massachusetts. He often donates his photography works to nonprofit organizations that benefit families and children.

Tahitian Noni International (TNI) announced a new $250,000 Bioactive Beverage Challenge to all makers of superfruit juices in the network marketing industry. TNI believes that their Tahitian Noni^® Original Bioactive Beverage™ is so unique that no other product in the industry will measure up to it.

Accelr8 Technology Corporation (NYSE Amex: AXK) today announced that it has received acceptance to present results for a study on 2-hour, culture-free, quantitative pathogen identification. The study was co-authored with principal investigators at the Denver Health Medical Center and the Barnes-Jewish Hospital in St. Louis. The presentation will take place at the 110th General Meeting of the American Society for Microbiology (ASM, www.asm.org) to be held from May 23-27 in San Diego. Tests performed directly from specimens accurately identified three target pathogens that are the most resistance–prone bacteria responsible for hospital-acquired infections (HAI).

Vitacost.com, Inc. (NASDAQ: VITC), a leading online retailer and direct marketer of health and wellness products, today announced Ira Kerker, the Company's Chief Executive Officer, and Richard Smith, the Company's Chief Financial Officer will participate in the Roth 22nd Annual OC Growth Stock Conference on March 16, 2010 at the Ritz-Carlton, in Laguna Niguel, CA.

PacificHealth Laboratories, Inc. (OTCBB: PHLI), a nutrition technology company, today announced that it has partnered with Saddleback Ltd. to distribute ACCELERADE™ products in the United Kingdom ("UK") to the cycle sport industry.

Cambridge Major Laboratories, Inc., Avantium Pharma, Xcelience, LLC and Beckloff Associates have formed a consortium of expert client-focused companies to launch Chemistry Playbook®, an expedited CMC solutions program designed to accelerate drug development.

Healthways, Inc. (NASDAQ: HWAY) will participate in the Barclays Capital 2010 Global Healthcare Conference to be held March 23-24, 2010, in Miami, Florida. Ben R. Leedle, Jr., Healthways chief executive officer, will present at the conference at 1:30 p.m. EDT (12:30 p.m. CDT), Tuesday, March 23, 2010. The presentation and presentation materials will be available live online and also for replay on the "Investors" section of the Company's website, www.healthways.com. Please go to the site at least 15 minutes prior to the presentation to download and install any necessary audio software.

Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that David P. Southwell has been named Executive Vice President and Chief Financial Officer. He will report directly to H. Thomas Watkins, President and Chief Executive Officer, and will serve as a member of the Management Committee of the Company. Mr. Southwell has served as a member of the HGS Board of Directors since July 2008, and he is resigning from the Board to accept this new position. His new appointment is effective March 22, 2010.

Inovio Biomedical Corporation (NYSE Amex:INO), a leader in DNA vaccine design, development and delivery, announced today that Dr. J. Joseph Kim, President and CEO, will present at Roth Capital Partners' 22nd Annual OC Growth Stock Conference on Monday, March 15^th at 9:00 a.m. PT (12:00 noon ET). The conference is being held March 15-17, 2010, in Dana Point, California.

MedAssets (NASDAQ: MDAS) announced today that Dallas-based Odyssey HealthCare, Inc. (NASDAQ: ODSY), one of the largest providers of hospice care in the United States, has signed a multi-year agreement to use MedAssets' Web-based revenue cycle management solutions to improve cash flow and business office efficiency and to ensure reimbursement integrity.

BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced today that Dr. Mark A. Sirgo, President and Chief Executive Officer, will present at the ROTH Capital Partners 22^nd Annual OC Growth Stock Conference at The Ritz-Carlton, Laguna Niguel in Dana Point, California. The presentation is scheduled for Monday, March 15 at 11:00 AM Pacific Time.

After a seven-day trial, a federal jury in Colorado rendered a verdict finding that Allergy Research Group (ARG), a subsidiary of the Kikkoman Corp. (OTC: KIKOF.PK), violated Federal false advertising laws in marketing their product, "Russian Choice Immune," as identical to the immune system support supplement Del-Immune V^®, previously marketed by ARG as Delta-Immune. The jury also determined that ARG misled buyers as to the product's origin – Russian Choice Immune was actually developed and manufactured in Vietnam – then sent it to the U.S. without conducting any prior research, according to the testimony of ARG's own expert, Dr. Ba Hoang.

Care Communications, Inc., a nationally recognized leader in the health information management (HIM) industry, announced today that its president, Patty Thierry Sheridan, MBA, RHIA, has been nominated for the role of President-elect of the American Health Information Management Association (AHIMA). The election will take place June 7-25, 2010.

BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced pre-clinical data the Company will present at 1:15 CST today at the 2010 Orthopedic Research Society (ORS) meeting in New Orleans. The Company's sports medicine team will present results of two pre-clinical studies demonstrating that rhPDGF-BB, in combination with tissue specific matrix materials, promotes healing in tendon-tendon and tendon-bone injuries. In addition, in vitro data demonstrating rhPDGF-BB's ability to stimulate tenocytes (tendon cells) will also be presented.

Safeguard Scientifics, Inc. (NYSE: SFE), a holding company that builds value in growth-stage life sciences and technology companies, today launched its corporate blog at blog.safeguard.com. The blog offers insights into Safeguard's strategy, performance and perspectives on the markets, as well as developments at Safeguard's partner companies.

AbleNet, Inc. – USA's Vice President of International Business, Adam Wing, will be making two presentations in Dubai. The Dubai Autism Center and the Dubai International Rehabilitation Forum have Wing presenting on March 16, 2010 on assistive technology solutions for those with a broad range of disability.

Researchers from four laboratories that perform diagnostic genetic testing of chromosome abnormalities in individuals with unexplained physical and developmental disabilities recently identified a previously unrecognized genetic disorder.

AIDS Healthcare Foundation (AHF):

Javelin Pharmaceuticals, Inc. (NYSE - Amex: JAV) recently reported its audited financial results for the full year and quarter ending December 31, 2009.

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced that new data for BMS747158, the company's novel drug candidate in clinical development as a Positron Emission Tomography (PET) perfusion imaging agent, will be featured in an oral presentation at the American College of Cardiology 59^th Annual Scientific Session taking place March 14-16, 2010 in Atlanta. BMS747158 is now known by the generic name flurpiridaz F 18. In addition, new data on LMI1195, the company's innovative PET imaging agent in clinical studies for heart failure, will be highlighted in a poster presentation.

Medex Inc. (MDXX:PK), today announced the appointment of Larry G. Shea to the position of Chief Operating Officer and member of the Company's board of directors.

Ischemix today announced the initiation of patient accrual in a multi-center Phase 2a clinical trial of CMX-2043 for the prevention of peri-operative ischemia-reperfusion injury in patients undergoing elective percutaneous coronary intervention (PCI) procedures. CMX-2043 is a cardio-protective drug that combines Akt pathway-mediated cell survival effects and anti-oxidant activity in a single small molecule.

ClearCount Medical Solutions, an innovator of patient safety solutions for the operating room, today announced that it has appointed David Haffner as its Chief Financial Officer. In this role, Mr. Haffner will oversee the day-to-day financial operations of the company, and will be responsible for the financial strategy as the company's product sales increase.

BioImagene, Inc., the leading provider of end-to-end digital pathology solutions, today announced the availability of the iSlide™ input device, an innovative device that allows pathologists to use a microscope-like interface to manipulate digital images of slides.

In a case believed to be a United States first, the radiology team at Lucile Packard Children's Hospital has used prenatal magnetic resonance imaging to detect an often-misdiagnosed genetic disease.

Leading natural and organic snack food vender YoNaturals is receiving new support in its mission to replace junk foods and sugary beverages with healthier vended choices in our nation's schools.

RF Monolithics, Inc. (NASDAQ: RFMI) ("RFM") a leader in machine-to-machine (M2M) wireless communications announced today that it has secured a multi-year agreement with a major medical equipment manufacturer for its ultra-low power short-range radio, the Virtual Wire™ transceiver. The product has taken several years to attain various levels of qualification and is now in volume production. The agreement sets forth the customer's intent to continue use of this product, in volume, for the next 5 years. The terms of this supply agreement, including the name of the customer, are covered under a confidentiality agreement.

Real-Time Innovations (RTI), The Real-Time Middleware Experts, today announced that Still River Systems has selected RTI Data Distribution Service software for the Monarch250™ PBRT System. The Monarch250 is Still River's proton beam radiotherapy (PBRT) system that is under development for use by physicians and their patients at cancer centers around the world.

FedSources, a Washington Management Group company, today issued the latest figures in its "Agency Drivers" series – a series of monthly releases that provide high-level budget information for individual government agencies.

The TriZetto Group, Inc. today announced the early availability of its QuoteToCard solution, which offers healthcare payers end-to-end sales automation and proprietary integration to HealthConnect, an individual and small-group multi-payer portal with the nation's largest community of brokers and general agents. For payers using TriZetto's QuoteToCard solution, brokers will now be able to generate quotes, install cases, enroll members and print identification cards either directly from the payer's website or through an online marketplace.

Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), a biotechnology company engaged in the discovery and development of DNA- and RNA-based drug candidates targeted to Toll-like Receptors (TLR), today announced that it will discuss its drug discovery and development programs and provide a general corporate overview at the Roth 22^nd Annual Orange County Growth Stock Conference on Wednesday, March 17, at 1:30 p.m. PST (4:30 p.m. EST) at the Ritz Carlton Laguna Niguel in Dana Point, CA.

Promega and TOP srl have combined their industry leading technologies to provide the most sensitive tools for monitoring apoptosis in live mammals, an important biomarker in cancer studies. Under the agreement, the two companies are promoting the VivoGlo™ Caspase 3/7 Substrate for use with transgenic repTOP^TM reporter mice. The tools allow the direct visualization and quantification of apoptosis non-invasively in live mice.

Theragenics Corporation^® (NYSE: TGX), a medical device company serving the surgical products and prostate cancer treatment markets, today announced its Annual Meeting of Stockholders will be held on Thursday, May 13, 2010, at 9:00 a.m., Eastern Time, at The Ritz-Carlton, Atlanta (downtown), 181 Peachtree Street, N.E., Atlanta, GA 30303. The Board of Directors fixed the close of business on March 16, 2010, as the record date for the determination of the stockholders entitled to notice of, and to vote at, the meeting. It is anticipated that the Proxy Statement and Annual Report on Form 10-K will be mailed to the stockholders entitled to notice of and to vote at the Annual Meeting on or around April 7, 2010. The Proxy Statement and Annual Report on Form 10-K will also be available at www.theragenics.com. This announcement serves to satisfy the public disclosure requirement of the Annual Meeting of the Stockholders.

LYNX Medical Systems, a Picis company, announced today that Picis LYNX E/Point^® emergency department (ED) revenue management solution has achieved the Healthcare Financial Management Association's (HFMA) prestigious Peer Review designation following an independent board review and thorough 11-step evaluation process. This designation was earned after demonstrating to respected members of the healthcare finance community that E/Point meets the stringent demands of today's healthcare systems for effectiveness, quality and ease of use, price, proven value and superior customer and technical support.

Amcom Software, Inc. today announced that it is working with Rady Children's Hospital to implement unified communications solutions to support information sharing throughout its facilities. The San Diego-based hospital will leverage Amcom solutions for contact center operations, on-call scheduling, and staff messaging in concert with its Cisco PBX and phones. At the heart of the project is Rady Children's goal of enhancing the patient experience through more seamless communications among staff, patients, and their families.

Kay Bross has been named Program Director, Member and Vendor Relations for SAFE-BioPharma Association, the non-profit association that created and manages the SAFE-BioPharma® digital identity and digital signature standard for the pharmaceutical and healthcare industries.

RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that the Company's President and Chief Executive Officer, Noah D. Beerman, will present a corporate overview at the ROTH 22^nd Annual OC Growth Stock Conference on Wednesday, March 17, 2010 at 10:00 a.m. PT. This annual three-day conference will be held March 15-17 at the Ritz Carlton Laguna Niguel in Dana Point, CA.

Medicity, Inc. announced today that top-ranked health system Trinity Health, comprised of 44 hospitals and numerous healthcare facilities in eight states, went live with the first stage of its Novo Grid deployment – establishing electronic health information exchange (HIE) with 297 affiliated physician practices and 991 physicians in three months.

Since its founding in 2007, the Society for Minimally Invasive Spine Surgery (SMISS) has become the pre-eminent professional society for MIS surgeons. On March 1, 2010, the organization's educational activities expanded dramatically with the launch of SMISS Highlights, an online series of CME-accredited education modules that are free of charge for spine surgeons.

Biologics Consulting Group, Inc., a regulatory affairs consulting firm, is pleased to announce a key appointment to its highly-experienced team.

Intelerad Medical Systems, a recognized leader in medical imaging PACS and workflow solutions, today announced that Carolina Regional Radiology PA (CRR) will be leveraging InteleOne to interconnect its facilities. CRR is a full-service radiology practice serving a ten-county region in southeastern North Carolina. CRR employs 21 radiologists reporting over half-a-million studies per year, offering on-site services and teleradiology to two imaging centers, four hospitals, and more than a dozen small clinics.

Catalina Marketing Corporation, the global leader in precision marketing and shopper-driven media, today announced the appointment of Renee Selman as President of its health care division, Catalina Health Resource, responsible for managing strategic direction, day-to-day operations and overall unit performance.

Carticept Medical, Inc., a developer of innovative products for the treatment of cartilage injuries and osteoarthritis, today announced that it has completed a $20 million Series B financing round. New investor SonoSite, Inc. joined existing investors Domain Associates and New Enterprise Associates. The financing will provide funding for the expected commercial launch of the Company's Navigator^TM Delivery System, an integrated, computer-controlled, fluid delivery system designed to automate the delivery of medication for the benefit of both the patient and physician, as well to complete patient enrollment in the clinical study of the Company's Cartiva^TM Synthetic Cartilage Implant.

Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that FHN Hospital has selected ProVation® Order Sets, powered by UpToDate® Decision Support, to automate the creation, deployment and maintenance of order sets.

Merck & Co., Inc. (NYSE: MRK):

Quintiles gab heute die Eröffnung einer neuen Forschungseinrichtung in London, Großbritannien, zur Steigerung seiner Kapazitäten für Phase-I-Prüfungen und für mehr Möglichkeiten zur Weiterentwicklung der translationalen Medizin bekannt.

Diversey, Inc. and Diversey Holdings, Inc. today announced that management of both corporations will review financial results for fiscal year ending 2009 in a combined conference call on Friday, Mar. 19, 2010 at 10 a.m. EDT. Diversey President & CEO Ed Lonergan and Chief Financial Officer Norm Clubb will also participate in a question and answer session.

DexCom, Inc. (NASDAQ:DXCM) today announced that Steven R. Pacelli, Chief Administrative Officer, will present an update on DexCom at the 22^nd Annual ROTH OC Growth Stock Conference in Laguna Niguel on Monday, March 15, 2010 at 8:30 a.m. (PT). The presentation, which will occur live at the Ritz-Carlton Hotel in Laguna Niguel, will be concurrently webcast. The link to the webcast will be available on the DexCom, Inc. website at www.dexcom.com under the investor relations, events and webcast section, and will be archived for future reference.

On March 16, 2010, an anticipated 1,000 advocates will band together for lupus in person and virtually by phone, email, and through social media networks, to share their personal stories with Members of Congress during the Lupus Foundation of America's, (LFA) Twelfth Annual Advocacy Day.

On March 4 & 5, the surgical team from the Onassis Cardiac Surgery Center, led by Dr. Petros Sfirakis, Director of the Transplantation Department & Mechanical Support Unit and Dr. Louis Louca, Surgeon/VAD Coordinator, completed the first phase of certification training to implant the SynCardia temporary CardioWest™ Total Artificial Heart. Team members from St. Vincent's Hospital in Sydney, Australia, also attended the training, including Dr. Phillip Spratt, Head of Cardiopulmonary Transplant and Cardiothoracic Unit, Dr. Paul Jansz, Cardiothoracic and Transplant Surgeon, Mr. Claude Soto, Clinical Perfusionist and Ms. Desiree Robson, Cardiac Mechanical Assist Co-ordinator.

ZymoGenetics, Inc. (NASDAQ:ZGEN), today announced the presentation of safety and immunogenicity data among pediatric burn patients at the 42^nd Annual Meeting of the American Burn Association in Boston, MA. The study marks the first dedicated look at the safety and immunogenicity of any stand-alone thrombin in pediatric surgical patients. The investigators concluded that RECOTHROM did not appear to be associated with any treatment-related adverse events when used as an aid to hemostasis in pediatric patients undergoing synchronous burn wound excision and skin grafting. Additionally, none of the pediatric burn patients who were administered RECOTHROM during their surgical procedure developed product-specific antibodies through post-operative (post-op) day 29.

MagnaCare, (www.magnacare.com) a health plan services company with national reach, today announces plans to build on its stable customer base and dominant position in the fiercely competitive NY/NJ/CT region to expand into the broader health care services market. Pointing to innovative differentiators fueling continued growth and expanded market share, MagnaCare cites its ability to provide exemplary customer service and offer deep discounts to Taft-Hartley funds, self-insured companies, commercial insurers for health, workers' compensation, or no fault, Third Party Administrators (TPAs), and government entities.

Research and Markets(http://www.researchandmarkets.com/research/aba285/oral_hygiene_glob) has announced the addition of the "Oral Hygiene: Global Industry Guide" report to their offering.

Pharmadule AB, the world leader in high-tech modular facilities for the pharmaceutical and biopharmaceutical industries, has signed a contract with Sicor Biotech UAB in Vilnius, Lithuania for the delivery of a modular production facility. Pharmadule's scope comprises design, fabrication, installation and validation of a complete Biotech Production Facility. Pharmadule's modular concept allows 80% of the construction to be completed in Pharmadule's workshop resulting in a very high and predictable quality, a short delivery schedule and financial benefits for the customers.

Positron Corporation (OTCBB:POSC). The growth rate among nonradiologists who own or lease PET equipment was far higher than radiologists between 2002 and 2007, according to a study published in the March issue of the Journal of the American College of Radiology (JACR Volume 7, Issue 3, March 2010, Pages 187-191).

Research and Markets (http://www.researchandmarkets.com/research/78f76e/the_pharmaceutical) has announced the addition of Frost & Sullivan's new report "The Pharmaceutical Industry in Botswana" to their offering.

Research and Markets (http://www.researchandmarkets.com/research/9d53ba/systemic_fungal_in) has announced the addition of Frost & Sullivan's new report "Systemic Fungal Infection Therapeutics Market - South Korea" to their offering.

ACM Global Central Laboratory, the global central lab that continually defines the customer-service standard with its flexible approach, today announced the newest member of its Clinical Trials team, Nandan Rao as the general manager, Asia Pacific located in Mumbai, India. Initially, Rao will have oversight of trials conducted with ACM Global's partner lab in the region. He will also be building the ACM Global infrastructure and team throughout Asia Pacific, as a result of increased demand.

Research and Markets (http://www.researchandmarkets.com/research/fa31a5/china_veterinary_p) has announced the addition of the "China veterinary pharmaceutical manufacturing industry, 2010" report to their offering.

KBR (NYSE: KBR) announced that its Building Group has been awarded a $94 million contract by Piedmont Healthcare to provide preconstruction and construction services for a replacement facility for Piedmont Newnan Hospital in Newnan, Georgia. When complete, the new hospital is expected to be the tallest building in the southwest metropolitan Atlanta area. The Building Group's Nashville and Atlanta offices are responsible for this significant healthcare construction project, which represents the first phase of a long-term building program planned for this campus.

ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today reported its financial results for the fourth quarter and year ended December 31, 2009.

Top rankings for brand value, trust, and the charity people are most likely to donate to, affirm the strength of the 28-year promise of Susan G. Komen for the Cure®: the world's largest breast cancer organization: to save lives and end breast cancer forever.

ZenBio announce that they will be a commercial source for the popular murine 3T3-L1 cell line, which has been fundamental in metabolic disease research for 30 years. Originally derived from Swiss mouse embryo tissue by Dr. Howard Green of the Department of Cell Biology at Harvard Medical School, the 3T3-L1 system has been pivotal in advancing the understanding of basic cellular mechanisms associated with diabetes, obesity and other related disorders.

NexMed, Inc. (Nasdaq: NEXM), a specialty CRO with a pipeline of products based on the NexACT® technology, announced today that Bassam Damaj, Ph.D., President and Chief Executive Officer, will present an overview of the Company at 1:00 p.m. Pacific Time on Wednesday, March 17, 2010 at the Roth 22^nd Annual OC Growth Stock Conference.

Angeion Corporation (NASDAQ: ANGN) today announced that Scott Shuda has been named to the company's board of directors.

Goldberg Kohn proudly represents Dr. Robert Goldberg and June Beecham in their lawsuit against Rush University Medical Center, Midwest Orthopedics, LLC, Rush Surgicenter, Ltd. and Brian Cole, MD.

NMT Medical, Inc. (NASDAQ: NMTI) today announced that it will release its fourth-quarter and year-end 2009 financial results before the market opens on Thursday, March 25, 2010.

Hercules Technology Growth Capital, Inc. (NASDAQ:HTGC), the leading specialty finance company providing venture debt and equity to venture capital and private equity-backed technology and life science companies at all stages of development, today announced that it has increased its commitment to grow the operations of InfoLogix, Inc. (NASDAQ:IFLG), a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries. Hercules invested an additional $3.0 million of capital to fund the launch of two new strategic product offerings with high growth potential.

Urigen Pharmaceuticals, Inc. (OTCBB:URGP), a specialty pharmaceutical company focused on the development of treatments for urological disorders and pain, announced today that video of the recent presentation made by Prof. Lowell Parsons in Atlanta on February 25^th, 2010 is now available at www.urigen.com.

Alpha Pro Tech, Ltd. (NYSE Amex: APT), a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel, and building products, today announced record financial results for the fourth quarter and the full year ended December 31, 2009.

In response to a petition seeking to amend state health regulations to better protect workers in the adult film industry that was filed in December by AIDS Healthcare Foundation (AHF), California's Department Occupational Safety and Health (Cal OSHA) is recommending that an advisory panel be convened to determine whether—and how—to amend state health statutes to better protect such film workers.

In the forefront of breaking technology, CoActiv Medical (Booth 635) announces at the American Academy of Orthopaedic Surgeons (AAOS) conference new EXAM-PACS touch screen image viewing for the recently announced Apple iPad large-screen digital viewing and communications device. Based on the existing EXAM-PACS iPhone image viewing system incorporated in its orthopedic and other PACS solutions, the new iPad system will support bi-directional data communication between a PACS and any iPad using the new device's built-in WiFi capabilities. This version of EXAM-PACS for iPad will also be fully compatible with the Apple iPad 3G model scheduled for release in April. The updated 3G model will allow connectivity for anywhere, anytime image viewing.

Dialysis patients, family members and kidney care advocates from across South Carolina will travel to the State House tomorrow to urge state Senators to support Medigap legislation – S. 1128, sponsored by Senators Harvey Peeler (R-Cherokee) and Phillip Shoopman (R-Greenville). South Carolina kidney patients are joined in advocating for this legislation by the National Kidney Foundation Serving the Carolinas, South Carolina Region (NKF) and Dialysis Patient Citizens (DPC). If enacted, the bill will help approximately 500 South Carolinians suffering from kidney failure and patients deemed disabled who are having difficulty accessing private market health insurance coverage for necessary medical care.

According to Fitch Ratings, the remarketing of Michigan State Hospital Finance Authority (MI) (Ascension Health Credit Group) variable rate revenue bonds series 1999B-1 does not affect the bonds' current ratings.

IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of body-worn medical and electronics devices, today announced financial results for its 2009 fourth quarter and full year ended December 31, 2009.

InSite Vision Incorporated (OTCBB: INSV) today reported financial results for the full year and fourth quarter ended December 31, 2009.

SmallCapVoice.com, Inc. announced today that part 2 of a 2 part new audio interview with BioElectronics Corp. (Pink Sheets:BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices is now available. The interview can be heard at http://smallcapvoice.com/blog/3-5-10-audio-interview-with-bioelectronics-corporation-part-2.

DexCom, Inc. (Nasdaq:DXCM) today reported its audited financial results as of and for the quarter and fiscal year ended December 31, 2009.

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced financial and operating results for the fourth quarter and full year ended December 31, 2009.

Catholic Charities Health and Human Services (Catholic Charities) has introduced a transformational leadership development program called Catholic Emerging Leaders (CEL). The CEL Program helps emerging leaders develop their leadership skills, knowledge and exposure. The goals of the program are to:

People with MS (Multiple Sclerosis) and others suffering with a range of often debilitating inflammatory conditions such as Chronic Fatigue Syndrome and Fibromyalgia, will take heart from advances in treatment for their conditions, and will follow events at The 2nd European LDN Conference with interest.

In one of the more unusual cases to confront the Colorado courts, the El Paso County Probate Court in Colorado Springs has granted Holme Roberts & Owen (HRO) client Alcor Life Extension Foundation of Scottsdale, Arizona, custody of the remains of Colorado Springs nurse Mary Robbins. The ruling upheld Ms. Robbins's 2006 agreement with Alcor to have her head cryonically preserved after death, hoping that future technologies could bring her back to life.

ACIST Medical Systems, Inc., a world-leading provider of contrast-delivery systems for cardiology and radiology imaging, announced today that HealthTrust Purchasing Group, LP (HealthTrust), Brentwood, Tenn., one of the leading health care group purchasing organizations, has awarded the company a three-year contract, effective December 1, 2009, for ACIST cardiovascular injection technology, the ACIST | CVi® Contrast Delivery System.

Inhibitex, Inc. (Nasdaq: INHX), today announced that Russell H. Plumb, President and Chief Executive Officer, is scheduled to present an overview of the company and its pipeline of differentiated antiviral compounds at the following two conferences:

The law firm of Stember Feinstein Doyle & Payne, LLC is investigating possible claims related to the labeling of Sunsweet Antioxidant Blend Dried Fruit Mixes, which is manufactured by Sunsweet Growers, Inc..

The Asbestos Disease Awareness Organization (ADAO), the leading organization serving as the voice of asbestos victims, today applauds Representative Steve Cohen (D-TN - 09) and cosponsors for introducing a resolution that declares the first week of April as "National Asbestos Awareness Week" and seeks to "raise public awareness about the prevalence of asbestos-related diseases and the dangers of asbestos exposure."

TriTech Software Systems, a leading provider of public safety and pre-hospital care software solutions, announces today it received approval from Ortivus AB and TriTech shareholders to complete the acquisition of Ortivus North America. In conjunction with the acquisition, Ortivus North America will be renamed TriTech Emergency Medical Systems.

Fitch Ratings takes the following rating action on Valley View Regional Hospital, Oklahoma as part of its continuous surveillance effort:

Publix Super Markets is issuing a voluntary recall for four (4) varieties of seasoning mixes. The products have been manufactured with HVP (hydrolyzed vegetable protein) supplied by Basic Food Flavors of Las Vegas, Nevada. The HVP may be contaminated with Salmonella. Consumption of products containing Salmonella can cause serious and sometimes fatal infections in young children, frail or elderly persons and others with weakened immune systems. The recalled products include all lot codes for the following items:

Golf Trust of America, Inc. ("GTA") (NYSE Amex: GTA) announced that GTA's stockholders voted to approve the four proposals that were conditions to closing the previously-announced merger between GTA and Pernix Therapeutics, Inc. ("Pernix") at a Special Meeting of Stockholders held earlier today. Holders of approximately 78.2% of Golf Trust outstanding common shares voted in favor of the proposal to issue the merger shares, or 99.2% of total shares voted. The combined company will be renamed Pernix Therapeutics Holdings, Inc. We currently anticipate the merger will close on March 9, 2010 and that trading will commence on the NYSE Amex under the symbol "PTX" on March 10, 2010.

ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to its IMGN901 compound when used for the treatment of Merkel cell carcinoma (MCC). Through a separate process, the European Union (EU) Committee for Orphan Medicinal Products (COMP) concurrently also granted IMGN901 orphan medicinal product designation for the treatment of MCC.

MedAssets, Inc. (NASDAQ: MDAS) today announced its Board of Directors has selected KPMG LLP to serve as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2010. KPMG replaces the Company's previous independent registered accountants, BDO Seidman, LLP which served as the Company's public accounting firm since 2004.

The most decorated U.S. Winter Olympian in history and star of the 2010 Winter Olympic Games, Apolo Anton Ohno has partnered with The Century Council and its Ask, Listen, Learn: Kids and Alcohol Don't Mix program. Today in California, Ohno, in conjunction with the newly formed Apolo Anton Ohno Foundation, began a five-city tour to schools throughout the U.S. encouraging kids to say "YES" to a healthy lifestyle and "NO" to underage drinking. The Apolo Anton Ohno Foundation, established by the eight-time Olympic medalist, will focus on providing youth of all ages and socio-economic backgrounds with the opportunity to play sports, be active and learn about the benefits of making responsible and positive choices.

The Herbalife Family Foundation (HFF) announced the opening of two additional Casa Herbalife programs in Mexico, in Tijuana, Baja California and Celaya, Guanajuato.

Throughout the month of March, visitors to Rockefeller Center in the heart of midtown Manhattan will get an unexpected lesson on Alzheimer's disease.

Flamel Technologies (NASDAQ:FLML) today announced its financial results for the fourth quarter and year ended December 31, 2009.

BioMimetic Therapeutics, Inc. (NASDAQ:BMTI) today announced that the Company plans to release its financial results for the three and twelve months ended December 31, 2009, on Thursday, March 11, 2010 after the close of market. The Company will host a conference call and audio webcast to discuss its fourth quarter and year-end financial results, product development programs and business activities at 8:30 a.m. EST Friday, March, 12, 2010.

Natrol, Inc., a premier marketer, manufacturer, and distributor of nationally branded nutritional products, introduces three new nutritional supplements -- Natrol^® MaquiBerry, Natrol^® Resveratrol Diet, and Natrol^® Resveratrol Weekend Cleanse -- with superfruit antioxidant capacity. These three new products join Natrol's popular line of açaí superfruit offerings -- including Natrol^® AçaíBerry 1,000 mg, Natrol^® AçaíBerry Diet, and, Natrol^® AçaíBerry Weekend Cleanse -- making Natrol the #1 Acai supplement brand at U.S. grocery stores, drug stores, and mass merchandise retailers.

The law firm of Stember Feinstein Doyle & Payne, LLC is investigating possible claims related to the labeling of Nestle Juicy Juice.

Exelixis, Inc. (Nasdaq:EXEL) today announced a restructuring as a consequence of its continued strategy to focus resources on the development of its key late-stage compounds. As its first priority, the company will aggressively advance XL184, XL147 and XL765, each of which is the subject of a large clinical development program. Additionally, Exelixis retains a fully integrated R&D organization, and will continue to advance new compounds into development, although the number will be reduced for the foreseeable future. Exelixis has retained the ability to meet all of its obligations to existing partners. Further, as a result of its retained R&D capabilities and its numerous unpartnered clinical and preclinical compounds, the company expects that its ongoing and future business development discussions will be unaffected.

Orthofix International N.V. (NASDAQ: OFIX) (the Company) announced today it has sold the assets of its vascular business, including its AV-Impulse^® mechanical compression technology, to Covidien.

Advaxis, Inc., (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, has confirmed the long-term stability of its first clinical formulation of ADXS11-001, the Company's lead immunotherapeutic.

Second graph, first sentence of release should read: "It was the right thing to do in 2006, and it continues to be the right thing to do today," said Sandy Douglas, president of Coca-Cola North America (sted "It was the right thing to do in 2006, and it continues to be the right thing to do today," said Sandy Douglas, president of Coca-Coca North America).

Michael A. Rashid, President and CEO of the AmeriHealth Mercy Family of Companies, the largest organization of Medicaid managed care plans and related businesses in the United States, announced today that Joyce S. Hagen has been appointed Chief Marketing and Development Officer of the company, effective immediately.

The Institute for Systems Biology, an independent, non-profit biomolecular research institute, has received a $6 million gift from a California venture capitalist and philanthropist to support strategic organizational objectives.

XenaCare Holdings, Inc. (OTCBB:XCHO), a company specializing in the marketing and retail distribution of consumer healthcare products, has announced today that it will be replacing advertisements scheduled to appear in the National Collegiate Athletic Association (NCAA) March Madness Tournament program and Final Four Game program with advertisements in Major League Baseball (MLB) yearbooks. The change in advertising occurred due to unforeseen timing circumstances with Professional Sports Publications, the publisher of the NCAA gameday programs.

Greyson International, Inc. (GYSN.PK) announced today its upcoming ShopNBC appearance has been moved to prime time. Veteran television personality and Greyson International CEO Harvey Tauman will appear as the spokesperson on behalf of the Company to feature the Company's new Trilexon® products on air on Wednesday, March 10, 2010 at approximately 7 p.m. EST during the "ShopBeauty" hour.

Top rankings for brand value, trust, and the charity people are most likely to donate to, affirm the strength of the 28-year promise of Susan G. Komen for the Cure®: the world's largest breast cancer organization: to save lives and end breast cancer forever.

Research and Markets (http://www.researchandmarkets.com/research/f36f7f/the_global_biotech) has announced the addition of the "The Global Biotechnology (Pharmaceuticals) Report" report to their offering.

Synovis Life Technologies, Inc. (Nasdaq: SYNO), a leading biomaterial and surgical products company, today announced that its board of directors has approved a program for the company to repurchase up to 1 million shares of its common stock, in addition to the approximately 66,000 shares remaining to be purchased under an existing share repurchase program approved by the board in September 2009. Synovis plans to make purchases in either the open market or through private transactions from time to time, in accordance with Securities and Exchange Commission regulations. The timing and extent to which the company buys back shares will depend on market conditions and other corporate considerations. The repurchase program does not have an expiration date. As of Jan. 31, 2010, the company had $56.5 million in cash, cash equivalents and investments. This represents the third stock buyback Synovis has announced in less than two years.

After dropping 17% in 2008 from an all-time high set in 2007, the average price paid per bed for skilled nursing facilities increased slightly in 2009, according to a new report on the seniors housing and care M&A market to be published by Irving Levin Associates, Inc., a research and publishing firm that tracks mergers and acquisitions in the seniors housing and health care markets. The skilled nursing industry has been resilient in the recent economic downturn, and despite uncertainty with regard to Medicaid and Medicare reimbursement, buyers were still finding opportunities in a relatively slow acquisition market. In the 2006 to 2007 period, prices were pushed up as Medicare and its higher rates became a more important part of the skilled nursing business, drawing more investors into the market. With the credit crunch and market uncertainty, this started to unravel, but not nearly to the extent as in other real estate-oriented sectors.

Crimson Life Sciences, the specialized medical device division of global language and business services leader TransPerfect, today announced that the company's president, Marc H. Miller, will present at a full-day industry conference hosted by the New England Biomedical Division of the American Society for Quality (ASQ). The conference, titled "International Compliance: Supporting Global Medical Device Marketing Initiatives beyond the US, Canada & Europe," will take place on Thursday, March 11, at the Waltham Woods Conference Center—agenda and registration information can be found here.

Today, the Coca-Cola system in the U.S. proudly joined with the William J. Clinton Foundation, the Alliance for a Healthier Generation and members of the American Beverage Association (ABA) to announce that it has successfully delivered on its three-year commitment to increase the availability of no- and low-calorie beverages to schools across the country. As a result, the industry has driven an 88 percent reduction in total calories from beverages delivered to schools in the first half of the current school year, as compared to the first of the 2004-2005 school year.

The AmeriHealth Mercy Family of Companies today announced that Jay Feldstein, DO, has been named Interim Regional President of the Northeast Region and Corporate Chief Medical Officer.

Nuvilex, Inc. (OTC Bulletin Board: NVLX) announces today that it has entered into a letter of intent granting Nuvilex, Inc. an exclusive sixty-day right to define and structure a merger with the Energy Innovation Group, LLC (EIG) on mutually acceptable terms and conditions. EIG's mission is to bring a broad array of technology, inclusive of the latest advances in traditional and emerging technologies and incentive opportunities to the commercial and public sector marketplace to reduce energy consumption. Established in 2000 by Mr. Sidney Pelston, EIG is the developer of the Energy Grand Buffet, which has integrated all the critical elements for the commercialization of energy efficiency. EIG is a privately held and profitable company. Nuvilex is working with Mr. Victor Caron of Ideal Corporate Funding to assist the Company in its pursuit of EIG.

WhiteGlove House Call Health, Inc. (www.whiteglove.com), a new provider choice in medical care that offers affordable, high-quality routine care at the home or work, announced today that it has closed a series C round of funding to start expanding outside of Texas.

Research and Markets (http://www.researchandmarkets.com/research/e69457/biotechnology_sect) has announced the addition of the "Biotechnology Sector" report to their offering.

"Now this punch drunk grinning soul, in its corner begs no more." Lyrics made more haunting by Flogging Molly's new music video for their single, "Punch Drunk Grinning Soul." Originally penned as an allegorical biography about a young man who unexpectedly committed suicide, the video takes the theme one step further and applies it to a malady faced by millions of people the world over – post traumatic stress disorder or PTSD. The video begins with a public service announcement for PTSD narrated by singer Dave King and Mike Regan, a distinguished Vietnam war veteran and the father of the band's fiddle player, Bridget Regan.

Michael A. Rashid, President and Chief Executive Officer of the AmeriHealth Mercy Family of Companies, today announced that Anne Morrissey has been named Executive Vice President and Chief Operating Officer of the company. AmeriHealth Mercy is the largest organization of Medicaid managed care plans and related businesses in the United States, touching the lives of more than 6.5 million members.

Research and Markets (http://www.researchandmarkets.com/research/97ea99/the_global_generic) has announced the addition of the "The Global Generic Pharmaceuticals Industry Report" report to their offering.

Ten Wisconsin biotechnology companies have been awarded scholarships of $1,100 each to support them in attending the Biotechnology Industry Organization's (BIO) International Convention at Chicago's McCormick Place May 3-6, 2010 in Chicago. All recipients plan to participate in BIO's one-on-one partnering with potential customers from around the world, or to present to potential investors.

Virtual Radiologic Corporation (NASDAQ:VRAD), a national radiology practice, has been awarded the Stevie® Award for Best Use of Technology in Customer Service in the fourth annual Stevie Awards for sales and customer service.

ROTH Capital Partners (ROTH), www.roth.com, a full service investment bank recognized for providing financing and advisory services to emerging growth companies worldwide, today announced that the upcoming 22nd Annual OC Growth Stock Conference will feature a Media and Internet Track with presentations from leading companies in advertising, entertainment, content distribution and exhibition, media technology, and e-commerce. The invitation-only conference will be held March 15-17, 2010 at The Ritz Carlton, located at 1 Ritz Carlton Drive, Dana Point, California.

PharPoint Research, Inc., a drug development service company providing biostatistics and data management services to the pharmaceutical and biotechnology industries, announces that it has incorporated Medrio's EDC technology platform into its growing suite of data management applications.

Implantable Provider Group (IPG), a leading provider of implantable device management, announced today that it has secured an investment from Sequoia Capital. The funding will enable IPG to invest in future growth initiatives.

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, today announced its schedule of upcoming investor events.

Millennium: The Takeda Oncology Company today announced the presentation of safety, pharmacokinetic and efficacy data from the Phase I portion of a Phase I/II clinical trial evaluating TAK-700 in patients with metastatic castration resistant prostate cancer (mCRPC). These data were presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU), held March 5-7, 2010 in San Francisco, CA.

Nancy Hudecek, RN, BSN, MS, has joined AirStrip Technologies^TM as the Vice President of Clinical Excellence and Risk Management, AirStrip officials announced today.

X-spine Systems, Inc., a global manufacturer of implants and instruments for spinal surgery, announced today that it has entered into an exclusive license agreement with Gamma Spine for the development and distribution of its minimally invasive spinal fixation technology. Gamma Spine, founded by Dr. Vijay Goel, Ph.D., will participate in the development process with X-spine. "I am thrilled be working with Dr. Goel, who is one of the world's most renowned and published experts in spinal biomechanics, to develop this unique and valuable technology," stated Dr. David Kirschman, President and CEO of X-spine. The patent-pending device allows for the fixation of adjacent vertebral segments with minimal tissue disruption while attaining the biomechanical advantages of a traditional full-exposure system.

P.F. Chang's China Bistro (NASDAQ: PFCB) announced today a newly expanded Gluten Free Menu, featuring beef entrees for the first time. Gluten intolerant diners can now enjoy a wider range of dining options, from P.F. Chang's signature Chicken Lettuce Wraps and Mongolian Beef to a Flourless Chocolate Dome for dessert.

Bristol-Myers Squibb Company (NYSE:BMY) will present at the 30^th Cowen and Company Health Care Conference on Tuesday, March 9, 2010 in Boston. Lamberto Andreotti, president, chief operating officer and CEO-designate, Bristol-Myers Squibb, will make a formal presentation about the company at 1:30 p.m. ET on March 9.

Taro Pharmaceutical Industries Ltd. ("Taro" or the "Company," Pink Sheets: TAROF) today reported that it received approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application ("ANDA") for Fluorouracil Topical Cream USP, 5% ("fluorouracil cream").

Atlas Holdings LLC ("Atlas") has acquired certain assets of Portland, Oregon based North Pacific Group, Inc. ("NPG") related to NPG's utility and construction, food and agriculture, and hardwood and industrial products divisions. The assets were acquired by an Atlas affiliated entity, Bridgewell™ Resources LLC ("Bridgewell Resources" or "Bridgewell").

Omthera Pharmaceuticals, Inc., an emerging specialty pharmaceutical company focusing on the clinical development of new dyslipidemia therapies, today announced commencement of operations in Bedminster, New Jersey. Omthera's lead product candidate, Epanova™, an Omega 3 fatty acid containing a novel formulation of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), has shown promising results in lowering triglycerides in earlier clinical trials, as well as an excellent safety and tolerability profile. The Omthera management team includes drug development and commercialization expert Jerry Wisler, president and chief executive officer, and cardiologist and clinical expert Michael Davidson, M.D., chief medical officer.

Starkey Laboratories, Inc., one of the world's leading hearing technology companies, is excited to announce an exclusive licensing agreement with Nickelodeon & Viacom Consumer Products (NVCP) to launch co-branded pediatric hearing aids. The pediatric earmolds specifically created for children ages 0-13 will feature characters from Nickelodeon's most popular TV shows, including SpongeBob SquarePants, iCarly, Go, Diego, Go! and Dora the Explorer.

American CareSource Holdings (NASDAQ: ANCI) announced today that Matthew D. Thompson, Vice President, Finance, has been named Interim Chief Financial Officer. Thompson replaces Steven J. Armond, whose employment with American CareSource Holdings has ended effective immediately.

CardiacAssist Inc. announced today that it will exhibit its TandemHeart® System (Booth 356) in Atlanta at the American College of Cardiology (ACC) 59th Annual Scientific Session that begins on Sunday, March 14^th, at the Georgia World Congress Center.

Celldex Therapeutics, Inc. (NASDAQ: CLDX) today announced that Anthony S. Marucci, President and Chief Executive Officer of Celldex Therapeutics, Inc., will present at the 30^th Annual Cowen & Company Health Care Conference at the Boston Marriott Copley Place on Wednesday, March 10, 2010 at 11:00 a.m. Eastern Time.

Harvard University and Dana-Farber Cancer Institute announced today that they have concluded a major licensing agreement with Acetylon under which Harvard and Dana-Farber granted an exclusive therapeutic license to a robust platform technology and chemical methodology that enables high-throughput screening and lead optimization for HDAC inhibitor compounds. Under terms of the Agreement, Harvard and Dana-Farber received equity from Acetylon, and will receive downstream royalty and milestone payments.

Acetylon Pharmaceuticals today announced an exclusive therapeutic license for a robust platform technology and chemical methodology to conduct high-throughput screening and lead optimization for HDAC inhibitor compounds, as well as a portfolio of small-molecule selective histone deacetylase (HDAC) enzyme inhibitors including the first-ever selective inhibitor of HDAC6. The license was granted to Acetylon by Harvard University and the Dana-Farber Cancer Institute. Acetylon is currently focused on the development of potential drug candidates based on next generation Class II-selective HDAC inhibitors. Class IIB enzymes such as HDAC6 have emerged as important targets in inflammatory disease, neurologic disease and broadly in cancer. The platform and methodology were discovered by two of Acetylon's scientific founders, James E. Bradner MD of the Dana-Farber Cancer Institute and Ralph Mazitschek Ph.D., now of the Massachusetts General Hospital, along with colleagues at Harvard and the Broad Institute of Harvard and MIT. Acetylon Pharmaceuticals believes that its next-generation, selective HDAC inhibitor compounds may accomplish enhanced clinical utility by reducing or eliminating the debilitating and sometimes life-threatening side effects associated with the current first-generation of non-selective HDAC inhibitors.

The Genetics Policy Institute (GPI) www.genpol.org , producer of the 2010 World Stem Cell Summit, announced that the Alliance for Regenerative Medicine (ARM) www.alliancerm.org will be an educational partner of the 2010 Summit, taking place in Detroit, Michigan on October-4-6. Several ARM leaders will contribute presentations focusing on policy and industry issues relating to regenerative medicine.

Medica today announced the launch of the Medica Research Institute as a non-profit company that will serve as the research arm within the broader organization. Built on the principals of systematic investigation, some potential areas of study include health services research, comparative effectiveness research and clinical trial studies.

Gannett (NYSE:GCI) is offering promotional support to ClearChoice Dental Implant Centers, the No. 1 dental implant provider in the U.S., to help current members of the military and military veterans who have developed dental problems related to their service.

As the spring sun begins to shine, we all look forward to putting this season's very wet weather behind us. According to pest experts, the wet winter will be a perfect breeding ground for pests, and termites are no exception. Long considered one of the most prevalent and damaging pests in the South, termites will cause more than $5 billion in property damage this year alone. And that damage, says Arrow pest expert Shay Runion, is not usually covered by homeowners' insurance. Runion encourages homeowners to learn more about termite control to protect their most important investment.

In a letter to the CEOs of UnitedHealth Group Inc., WellPoint Inc., Aetna Inc., Health Care Service Corporation and CIGNA HealthCare Inc., U.S. Department of Health and Human Services (HHS) Secretary Kathleen Sebelius called on the executives to publicly justify proposed health insurance premium increases. Sebelius' letter comes after a meeting last week with these executives at the White House.

Anika Therapeutics, Inc. (NASDAQ:ANIK) today announced that Charles Sherwood, president and chief executive officer, will be presenting at the Canaccord Adams Musculoskeletal Conference on Tuesday, March 9, 2010 at 9:00 a.m. CT (10:00 a.m. ET). A live audio webcast of the presentation may be accessed via the Internet at: http://www.newswire.ca/en/webcast/viewEvent.cgi?eventID=2953940. In addition, the presentation will be available live at the "Investors" section of Anika's website at www.anikatherapeutics.com. Dr. Sherwood will be discussing the current state of the business, including the Company's recent acquisition of Fidia Advanced Biopolymers.

Corning Incorporated (NYSE: GLW) today announced the Corning Lab for the Cure™ program, a first-of-its-kind corporate sponsorship agreement with Susan G. Komen for the Cure^®. Under terms of the agreement and through a one-time donation of $250,000, Corning Life Sciences will engage with Susan G. Komen for the Cure throughout 2010 in co-marketing and co-branding initiatives to increase awareness for Komen's promise to save lives and find a cure for breast cancer.

The State of Pennsylvania notified Aetna (NYSE: AET) that it has awarded a Medicaid managed care contract to Aetna Better Health,^SM Aetna's Medicaid business.

Research and Markets (http://www.researchandmarkets.com/research/2e0e00/global_probiotics) has announced the addition of the "Global Probiotics Market: Trends and Opportunities" report to their offering.

Ventas, Inc. (NYSE:VTR) ("Ventas" or the "Company") announced today that Standard & Poor's Ratings Services ("S&P") has revised the outlook on the Company's corporate credit rating to positive from stable. S&P also affirmed the Company's current investment grade (BBB-) corporate credit rating.

Lauth® Group CEO Robert Lauth, has been elected to his second term on the board of St. Vincent Health, the state's largest healthcare employer encompassing 18 health facilities, serving 45 counties in central Indiana and recognized nationally for its exemplary community service.

Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced the results from the recent tender and increased conversion periods of the 4 percent convertible notes due in 2013. As a result of the sale of the specialty pharmaceutical business on January 29, 2010, the Company was required to offer to repurchase for cash any and all of its convertible notes at face value. This offer expired on March 5, 2010 and no notes were tendered.

Research and Markets (http://www.researchandmarkets.com/research/a06cce/what_health_care_l) has announced the addition of the "What Health Care Lawyers Need to Know About New Federal HITECH Act Rules and Health Breach Notification Rules Effective in February 2010" audio conference to their offering.

Aufsichtsrat und Vorstand der Sartorius AG haben in ihrer heutigen Sitzung beschlossen, der Hauptversammlung am 21. April 2010 vorzuschlagen, eine im Vergleich zum Vorjahr unveränderte Dividende in Höhe von 0,42 Euro je Vorzugsaktie bzw. 0,40 Euro je Stammaktie auszuschütten.

Bioness Inc. announces that its Board of Directors named Thomas G. Fogarty as the company's new President and CEO, effective February 4th. Fogarty succeeds former President and CEO Yitzhak Zilberman, who has left the company.

The Healthcare Billing & Management Association (HBMA), a non-profit educational resource and advocacy group representing third-party medical billers and billing professionals, announced today details of the association's 2010 Spring Educational Conference. This year's conference takes place at the Baltimore Marriott Waterfront, April 14-16, 2010, and will provide attendees the opportunity to learn about recent and imminent changes in the healthcare industry.

Molecular dermatology research and development innovator DermaGenoma, Inc. today released The HerpesDX Genetic Test for Frequent Genital Herpes. The new screening test will help doctors assess patients' risk for developing frequent Genital Herpes (HSV-2) outbreaks.

biospace med (www.biospacemed.com) announced today that it has received 510(k) clearance from the FDA (Food and Drug Administration) to market the Company's sterEOS 2D/3D workstation for pediatric use in spine applications. The Company's EOS ultra-low-dose imager previously has been FDA-cleared for use in pediatrics and adults, while sterEOS has previously been FDA-cleared for adult use in spine.

CIGNA (NYSE:CI) is announcing today that it is rolling out Intuit Inc.'s (Nasdaq: INTU) Quicken Health Expense Tracker^SM online bill payment for its medical and pharmacy plan customers - at no additional charge.

RepRegen™, the ‘smart biomaterials' company previously known as BioCeramic Therapeutics, announced today that data from an in vitro study has demonstrated that its patented Strontium-based bioactive glass platform promotes osteoblast cell activity and proliferation. If in vivo studies, which are currently underway, demonstrate similar results, then RepRegen believes its platform has the potential to significantly improve the repair and regeneration of hard-tissue, such as bone. The in vitro study was presented yesterday in a science session during the 56th Annual Meeting of the Orthopaedic Research Society (ORS) by Matthew O'Donnell, Ph.D., R&D Manager for RepRegen.

SmallCapVoice.com, Inc. announced today that part 1 of a 2 part new audio interview with BioElectronics Corp. (Pink Sheets: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices is now available. The interview can be heard at http://smallcapvoice.com/blog/3-5-10-audio-interview-with-bioelectronics-corporation-part-1.

HumanaOne®, the individual health division of Humana Inc. (NYSE: HUM), has introduced a new individual vision insurance plan on www.humanaonedental.com. With the launch of this new product, HumanaOne is also expanding its affordable vision insurance plans to a number of states it had not previously served.

Entelos, Inc., a simulation and modeling company focused on human health, and RegeneMed, Inc., a tissue-based drug discovery and regenerative medicine company, announced today the release of iToxFX™.

MicroSun Technologies, an industry leader in customized alternative power sources for the medical, commercial and military markets, announced today that John Gatti has joined the company as President and Chief Operating Officer for the U.S. and Malaysia. Mr. Gatti will also serve as Executive Vice President and Chief Operating Officer of MicroSun Electronics.

iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis and workflow solutions for the early identification of cancer, announces that the United States Patent and Trademark Office recently granted the company Patent Number 7,660,448. This patent covers future iterations of iCAD's SecondLook^® Digital Computer-Aided Detection (CAD) solution with potential application to the company's other image analysis solutions. iCAD has developed and now patented this technology, which incorporates CAD lesion metrics to provide clinicians with enhanced clinical information.

Precision BioSciences, Inc., today announced that the United States Patent and Trademark Office (PTO) has issued non-final Actions Closing Prosecution in the reexamination proceedings for U.S. Pat. Nos. 6,833,252 ("the ‘252 patent") and 7,214,536 ("the ‘536 patent") that are owned by the Institut Pasteur and the Universite Pierre et Marie Cure (UPMC), and licensed to Cellectis, SA (ALCLS). For the second time, the PTO has rejected all claims under consideration as lacking novelty and/or as obvious in view of a variety of references, including many that were not provided to the patent examiners during prosecution by the patent applicants.

Millennium Laboratories, Inc., a leading provider of therapeutic drug monitoring and education to physicians and staff treating chronic pain patients, announced today that Alun Malone has joined the company as Business Development Executive. He will be responsible for business development and implementing strategic initiatives, and will report to Howard Appel, President of Millennium Laboratories.

Response Genetics, Inc. (Nasdaq:RGDX) announced today that it has entered into a purchase agreement with certain new and existing investors and certain funds managed by Lansdowne Partners Limited Partnership to raise approximately $4 million from the private placement of 3,005,349 newly issued shares of its common stock, at a purchase price of $1.31 per share. The signing of the purchase agreement occurred on Friday, March 5, 2010. We expect the final closing of the shares will occur on Monday, March 8, 2010.

Genta Incorporated (OTCBB: GETA) announced today that the Company has entered into definitive agreements with institutional investors for a private placement of Convertible Notes totaling $25 million in gross proceeds. The transaction is expected to close on or about March 10, 2010, subject to the satisfaction of customary closing conditions. Proceeds of the financing will be used to ensure adequate followup to determine overall survival results from Genta's recently completed Phase 3 trial of Genasense® (oblimersen sodium) Injection plus chemotherapy as first-line treatment of patients with advanced melanoma (known as AGENDA) and to accelerate development of the Company's pipeline products, among other uses.

Argos Therapeutics today announced the presentation of positive data from a Phase 2 trial that evaluated the safety, clinical response and immune response of AGS-003 treatment in newly diagnosed patients with metastatic renal cell carcinoma (mRCC). The data were discussed March 7 in a poster presentation at the ASCO Genitourinary Cancers Symposium. AGS-003 is a product of the Company's Arcelis™ technology, and is a personalized, RNA-loaded, dendritic cell-based immunotherapy that is perfectly matched to each patient's unique tumor burden. According to results from the study, AGS-003 induced a tumor-specific immune response, performed better than interferon-α on a measure of progression-free survival, and was well tolerated.

SensAble Technologies, Inc®, a leading provider of 3D modeling software, haptic devices and dental restoration design and fabrication solutions, announced that it has received an $8 million investment to propel sales, marketing and engineering efforts for its digital dentistry product line. Existing investor HLM Venture Partners led the round and was joined by North Bridge Venture Partners, both of whom are headquartered in the Boston area, and have extensive expertise with medical device company funding.

DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), in conjunction with DaVita Clinical Research®, today announced that company representatives will present 20 presentations at the 30^th Annual Dialysis Conference (ADC) scheduled for March 6 – 9 in Seattle.

Kinetic Concepts, Inc. (NYSE: KCI) today announced it has received reimbursement approval from Japan's Health Insurance Bureau for use of the innovative V.A.C. ATS^® Therapy System in the country. The approval signifies an important advancement in the company's plans for market launch in April and follows Japan's Ministry of Health, Labor and Welfare's decision in November 2009 to grant final regulatory approval for the product.

Muscle Flex Inc. (www.MuscleFlex.com) (Pink Sheets:MFLI) announced today that it will develop its direct response television infomercial business exclusively under its health and fitness brand, Muscle Flex. Muscle Flex will become a "grittier" and "edgier" health and fitness brand within the company (BRAVADA International Ltd) that will be marketed to a demographic pre-disposed to an aggressive health and fitness lifestyle. The direct response infomercial business shall form an integral part of the Muscle Flex brand and will utilize a "hard" sales (call to action) approach in the design, marketing and feel of its DRTV and online marketing strategy. Through its trademarks and related intellectual properties, the company unequivocally owns "Muscle Flex" throughout the health and fitness idioms and believes the best way to maximize on the "Muscle Flex" brand is to market its products and services exactly as the name suggests; as an edgy and fitness focused brand. BRAVADA International Ltd will be the name of the parent company and the BRAVADA™ brand will engage in television, media, lifestyle and other related businesses on a macro scale. Additional details regarding the corporate and brand configuration shall be provided in a subsequent news release.

Research and Markets (http://www.researchandmarkets.com/research/bb25ca/ophthalmic_disease) has announced the addition of the "Ophthalmic Disease in Veterinary Medicine" report to their offering.

Jericho Systems Corporation, a leading provider of distributed SOA enterprise identity and access management solutions, exhibited at the annual RSA Conference held in San Francisco from March 1-5, 2010 in partnership with OASIS/XSPA.

Quintiles today announced the opening of its expanded research facility in London, UK, increasing its Phase I capacity and extending its ability to drive progress in translational medicine.

mtm laboratories, a privately held diagnostics company today announced the launch of CINtec^® PLUS, the company's next generation cervical cancer screening product with unmatched accuracy for the screening and management for cervical cancer. CINtec^® PLUS will be launched with claims direct in Germany, Italy, Spain, France and the UK, and will also be available in other parts of the world via mtm's nominated distributors.*

MabCure, Inc. (OTCBB:MBCI) ("MabCure"), a biotechnology company using its proprietary technology to create highly specific monoclonal antibodies (MAbs) for the early detection of cancer, today announced that it has recently completed a private placement in the aggregate amount of $1 million. The amount is comprised of a $500,000 cash investment and the conversion of a $500,000 bridge loan that was made in September 2009, into equity securities (together, the "Investment Transactions").

UPMC Health Plan, the second-largest health insurer in Western Pennsylvania, has gone live with ikaPortals, a comprehensive and integrated series of Web-based solutions from ikaSystems that open the plan's Web sites to direct small-group sales. Employers with between 2 and 50 employees can register online to evaluate health plan products, receive quotes, enroll their groups and initiate the member enrollment process, while their employees can complete their enrollment process — all online, without generating paper or involving insurance brokers.

PolyMedix, Inc. (OTC BB: PYMX, www.polymedix.com), an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, will be presenting at the Roth 22^nd Annual Growth Stock Conference. The Conference will take place March 15 – 17, 2010 at the Ritz-Carlton Laguna Niguel, CA.

Results from a study conducted by Majestic Research suggest that Bristol Myers Squibb's Orencia, Johnson & Johnson's Remicade, and Amgen's/Wyeth's Enbrel will forfeit share of the rheumatoid arthritis market to Roche's newly launched Actemra. Early switching data from Majestic's proprietary panel of rheumatologists indicates that Orencia may be the biggest loser of all, as 54% of switches to Actemra thus far have been from Orencia.

Ricerca Biosciences, LLC, announced today the finalization of the acquisition of the Discovery and Preclinical business of MDS Pharma Services with facilities and almost 600 associates in Bothell, Washington; Lyon, France; and Taipei, Taiwan.

Research and Markets (http://www.researchandmarkets.com/research/41fe5e/hearing_aid_market) has announced the addition of the "Hearing Aid Market Report: 2010 Edition" report to their offering.

Johnson Electric today announced the first of many new electronically commutated (EC) motors that are under development. This new brushless DC motor product line is designed for high efficiency, long life and precision détente torque performance in critical HVAC valve and damper control applications. http://www.johnsonmotor.com

Bovie Medical Corporation (the "Company") (NYSE-AMEX Symbol: BVX), a manufacturer and marketer of electrosurgical products, today announced that it has employed Mr. Leonard Keen, Esq. as Vice President and General Counsel, effective March 2, 2010. Mr. Keen is responsible for managing the Company's legal and strategic affairs, and working as a member of the executive management team to strengthen operations for growth and competitiveness.

The University of Texas at San Antonio (UTSA) celebrates the grand opening of its New Venture Incubator (NVI), a facility with laboratory, office and meeting spaces to support technology start-ups in the greater San Antonio region. The incubator, housed on UTSA's Main Campus, will serve as a bridge between San Antonio entrepreneurs and the region's research and development community.

Shaquille O'Neal has teamed up with Be The Match^® to tell the nation about the critical need for more bone marrow donors. In the Do Something Big^SM campaign, the basketball superstar will challenge Americans to "Be the one to save a life." Three public service announcements will hit the airwaves and the Internet starting in March.

Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the Japanese Patent Office has issued a patent for its novel anti-cancer compound, Archexin^®.

nanoMR, an emerging diagnostic company that develops real-time, ultrasensitive technology for detecting pathogens in biological samples, today announced the appointment of Colin W. Dykes, Ph.D., as chief scientific officer. His primary responsibility will be to establish studies that validate nanoMR's pathogen detection system in clinical settings.

CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical company specializing in oncology, today announced that CytRx President and CEO Steven A. Kriegsman and Vice President – Business Development David J. Haen will present at the Roth Capital Partners 22^nd Annual OC Growth Stock Conference on Tuesday, March 16, 2010 at 11:00 a.m. Pacific time (2:00 p.m. Eastern time). The conference is being held at the Ritz Carlton in Dana Point, California.

Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, announced today that Dr. Sanjiv Argawala, Principal Investigator for Provectus' Phase 2 PV-10 trial site at St. Luke's Hospital & Health Network in Bethlehem, PA, will present an update on the Company's ongoing Phase 2 trial of PV-10 for metastatic melanoma at the Seventh International Symposium on Melanoma and Other Cutaneous Malignancies on March 12, 2010, in New York City.

Please replace the release with the following corrected version due to multiple revisions.

SuperGen, Inc. (Nasdaq:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S.J. Manuso, Ph.D., President and Chief Executive Officer, will present at the ROTH 22^nd Annual Orange County Growth Stock Conference on Monday, March 15^th in Laguna Niguel.

TrovaGene, Inc., a developer of transrenal molecular diagnostics, announced today that Dr. Andreas Braun has joined the company as its Vice President and Chief Medical Officer. Dr. Braun has over 25 years of direct industry experience in developing molecular diagnostic assays for the clinical reference laboratory.

As Medicare Supplement insurers are positioning to gain market share, Mark Farrah Associates (MFA) is closely monitoring competitive shifts in the senior market. New Plans M and N will be introduced on June 1, 2010 and these plans, with lower premiums, are expected to gain traction and become popular choices among seniors. MFA recently released an analysis brief about Medigap. Here are some interesting highlights from New Medicare Opportunities with Medigap.

In response to its first-ever microsite on advanced soft tissue repair, Cook Medical has expanded CookBiodesign.com with new features including Q&A physician videos on biologics and links to the latest peer-reviewed articles, research and data on its Biodesign® Advanced Tissue Repair Products. The expanded site now offers surgeons and patients more than 800 educational resources on Biodesign products, which have been used in one million procedures and more than 91 countries for the treatment of conditions such as hernia, fistula, incontinence, pelvic organ prolapse and Peyronie's disease.

Mobile Aspects announced today that the University of Michigan Health System has signed an agreement to expand the use of its tissue tracking solution into the Operating Room at the University of Michigan C.S. Mott Children's Hospital. The solution, called iRISecure™, uses the unique characteristics of radio frequency identification (RFID) technology to automate clinical workflow associated with tissue tracking. In turn, a powerful solution is delivered to help care providers comply with process and procedural requirements from The Joint Commission and U.S. Food and Drug Administration (FDA) for the utilization of tissue and related products.

The TriZetto Group, Inc. today announced the appointment of Jeffrey Rideout, M.D., as senior vice president, care and cost management and as chief medical officer. Dr. Rideout will lead the systematic expansion of TriZetto's cost and quality of care solutions sets, including value-based benefits, value-based reimbursement and pharmacy utilization management, to help the company's payer customers drive greater value in care for members and providers.

Luminetx^®, a division of Christie Medical Holdings, Inc. and recently acquired by Christie Digital Systems USA, Inc., has signed an exclusive national sales distribution agreement with New Alliance of Independent Medical Distributors, Inc., DBA Alliance Medical. The agreement, effective last month, aligns the medical device company with Alliance Medical, the nation's largest consortium of specialty medical sales distribution companies for intravenous devices, with comprehensive access to the U.S. acute, oncology and home health markets.

The Journal of the American Academy of Dermatology (JAAD) has published Phase III data evaluating the safety and efficacy of imiquimod cream at two doses – 2.5% and 3.75% – administered daily on either 2-week or 3-week treatment cycles. While all study arms met the primary endpoint of complete clearance versus placebo, data suggest that, of the regimens studied, imiquimod 3.75% on a 2-week cycle is superior in treating actinic keratosis (AK) on a large surface area - the full face or balding scalp. AKs are considered to be the earliest stage in the development of skin cancer and have the potential to progress to squamous cell carcinoma (SCC).

Fluidigm Corporation today announced the release of 5kb and 10kb long-range PCR protocols for its Access Array™ System. Researchers interested in targeted re-sequencing projects for large cohort studies can use these new protocols and the Fluidigm Access Array System to amplify up to 48 samples per array. Long-range PCR enables new applications on the Access Array System by allowing researchers to enrich significantly more sequence per sample.

Research and Markets(http://www.researchandmarkets.com/research/00c0b5/ischaemic_heart_di) has announced the addition of the "Ischaemic Heart Disease, 1st Revised Edition" report to their offering.

Alpha Systems, a premier provider of electronic data and document management solutions, today announced that Butler Health System (Butler), an innovative healthcare provider located in Pennsylvania, has named Alpha Systems their vendor of choice for enterprise electronic document management (EDM) software. This move is designed to improve Butler's communication across the enterprise while moving the healthcare provider closer to a paperless environment.

Hooper Holmes (NYSE AMEX: HH) today announced that it will release fourth-quarter financial results before the market opens on Friday, March 12, 2010. The Company will host a conference call on Friday, March 12, 2010 at 11:00 a.m. Eastern Time.

ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that Jonathan Lewis, MD, PhD, Chief Executive Officer, will present at the 22^nd Annual Roth OC Growth Stock Conference on Monday, March 15, 2010 at 4:00 pm PT at the Ritz Carlton / Laguna Niguel, CA. Dr. Lewis will provide an overview of the Company and its clinical development programs.

RedBrick Health, the Health Earnings^SM company, today announced promising early 2010 health engagement results for several new clients.

ExonHit Therapeutics (Paris:ALEHT) and bioMérieux have decided not to pursue their collaboration in colon cancer, following a recent review of data by their scientific committee. Both companies continue to collaborate in the field of prostate cancer.

LUNA®, the maker of the Whole Nutrition Bar for Women®, introduces LUNA® Protein, the first high protein bar for women made with entirely natural and organic ingredients. It is an indulgent treat that satiates hunger and helps women more easily fit protein into their diet.

Depomed, Inc. (NASDAQ:DEPO) announced today that its president and chief executive officer, Carl A. Pelzel will be presenting at the ROTH 22nd Annual OC Growth Stock Conference in Laguna Niguel, CA on March 15, 2010 at 10:00 am PT.

John Muir Health Foundation, the charitable fundraising organization for all John Muir Health programs and services, has received a $1 million installment from the John Muir Medical Center Auxiliary, Walnut Creek towards their $2.5 million Capital Campaign pledge to support the current $621 million hospital expansion at the Walnut Creek Campus. In recognition of their leadership Campaign gift, a central rotunda in the new patient care tower will be named in honor of the Auxiliary.

The month of March brings with it the official start of spring – a season associated with renewal and romance, and, on a less lyrical level – with dusting, scrubbing, and otherwise engaging in the roll-up-your-sleeves ritual known as spring cleaning. While heavy-duty housework hardly sounds inviting, Health Net, Inc. (NYSE: HNT) wants to spread the word that spring cleaning not only results in a tidy abode, but also brings with it mental health benefits.

Cardiovascular death is the most common cause of mortality among Type 2 diabetics and claims the lives of millions each year, with many diabetics experiencing their first "symptom" as a heart attack or sudden death. Understanding that diabetics are at high risk for Coronary Heart Disease (CHD) and that many with the disease are asymptomatic, Toshiba America Medical Systems, Inc., has sponsored Speckle Tracking by Echo, a faCTor⁶⁴ substudy using Toshiba's Wall Motion Tracking ultrasound technology. faCTor⁶⁴ is a landmark study with Intermountain Healthcare to assess asymptomatic diabetics using cardiac CT angiography (CTA) with the Toshiba Aquilion^® 64 CT multi-detector row system.

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Cowen and Company 30^th Annual Health Care Conference in Boston, Massachusetts on Wednesday, March 10^th, at 10:15 a.m. ET and the Raymond James 31^st Annual Institutional Investors Conference in Orlando, Florida on Wednesday, March 10^th, at 11:00 a.m. ET. Management will present an overview of Charles River's strategic focus and business developments.

Integrated Healthcare Association:

Minneapolis' Target Center Arena was transformed into the world's largest cycling class today with the "Ride of a Lifetime." Hosted by Life Time Fitness (NYSE:LTM), the event was officially certified as a new Guinness World Record™ by Guinness Official, Kimberly Partrick, who attended the event and made the live post-event proclamation.

MDI Healthcare Solutions, Inc., announced today that two of the company's senior executives will present a roundtable discussion at the prestigious CFO Rising Conference, Navigating The New Normal on Tuesday, March 9^th in Orlando FL. The discussion, entitled, Rx for Health Care: Why an Integrated Approach to Health Care Spend Can Lower Costs will be presented by Andy Dengos, SVP of Sales & Business Development and Rick Farris, VP of Sales.

The most decorated U.S. Winter Olympian in history and star of the 2010 Winter Olympic Games, Apolo Anton Ohno has partnered with The Century Council and its Ask, Listen, Learn: Kids and Alcohol Don't Mix program. Today in Greenwood Village, Ohno, in conjunction with the newly formed Apolo Anton Ohno Foundation, began a five-city tour to schools throughout the U.S. encouraging kids to say "YES" to a healthy lifestyle and "NO" to underage drinking. The Apolo Anton Ohno Foundation, established by the eight-time Olympic medalist, will focus on providing youth of all ages and socio-economic backgrounds with the opportunity to play sports, be active and learn about the benefits of making responsible and positive choices.

AIDS Healthcare Foundation: